Lv3
355 积分 2021-11-08 加入
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas
1个月前
已关闭
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study
1个月前
已完结
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2–3 trial
1个月前
已完结
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma
1个月前
已关闭
High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial
1个月前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
3个月前
已完结
Cyclin D1 rearranged diffuse large B-cell lymphoma—an evolving concept
3个月前
已完结
Tumor Lysis Syndrome
3个月前
已关闭
Tumor Lysis Syndrome
3个月前
已完结
Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms
3个月前
已完结
皖公网安备34019202002308
